Literature DB >> 24946803

Probing the inherent stability of siRNA immobilized on nanoparticle constructs.

Stacey N Barnaby1, Andrew Lee1, Chad A Mirkin2.   

Abstract

Small interfering RNA (siRNA) is a powerful and highly effective method to regulate gene expression in vitro and in vivo. However, the susceptibility to serum nuclease-catalyzed degradation is a major challenge and it remains unclear whether the strategies developed to improve the stability of siRNA free in serum solution are ideal for siRNA conjugated to nanoparticle surfaces. Herein, we use spherical nucleic acid nanoparticle conjugates, consisting of gold nanoparticles (AuNPs) with siRNA chemisorbed to the surface, as a platform to study how a model siRNA targeting androgen receptor degrades in serum (SNA-siRNAAR). In solutions of 10% (vol/vol) FBS, we find rapid endonuclease hydrolysis at specific sites near the AuNP-facing terminus of siRNAAR, which were different from those of siRNAAR free in solution. These data indicate that the chemical environment of siRNA on a nanoparticle surface can alter the recognition of siRNA by serum nucleases and change the inherent stability of the nucleic acid. Finally, we demonstrate that incorporation of 2'-O-methyl RNA nucleotides at sites of nuclease hydrolysis on SNA-siRNAAR results in a 10-fold increase in siRNA lifetime. These data suggest that strategies for enhancing the serum stability of siRNA immobilized to nanoparticles must be developed from a dedicated analysis of the siRNA-nanoparticle conjugate, rather than a reliance on strategies developed for siRNA free in solution. We believe these findings are important for fundamentally understanding interactions between biological media and oligonucleotides conjugated to nanoparticles for the development of gene regulatory and therapeutic agents in a variety of disease models.

Entities:  

Keywords:  OliGreen; biological recognition; nanotechnology; polyacrylamide gel electrophoresis

Mesh:

Substances:

Year:  2014        PMID: 24946803      PMCID: PMC4103361          DOI: 10.1073/pnas.1409431111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Ribonuclease A.

Authors:  Ronald T. Raines
Journal:  Chem Rev       Date:  1998-05-07       Impact factor: 60.622

Review 2.  Chemical modification of siRNAs for in vivo use.

Authors:  Mark A Behlke
Journal:  Oligonucleotides       Date:  2008-12

3.  Lipid-like materials for low-dose, in vivo gene silencing.

Authors:  Kevin T Love; Kerry P Mahon; Christopher G Levins; Kathryn A Whitehead; William Querbes; J Robert Dorkin; June Qin; William Cantley; Liu Liang Qin; Timothy Racie; Maria Frank-Kamenetsky; Ka Ning Yip; Rene Alvarez; Dinah W Y Sah; Antonin de Fougerolles; Kevin Fitzgerald; Victor Koteliansky; Akin Akinc; Robert Langer; Daniel G Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-11       Impact factor: 11.205

4.  Chemical modification resolves the asymmetry of siRNA strand degradation in human blood serum.

Authors:  John A H Hoerter; Nils G Walter
Journal:  RNA       Date:  2007-09-05       Impact factor: 4.942

Review 5.  Progress toward in vivo use of siRNAs-II.

Authors:  Garrett R Rettig; Mark A Behlke
Journal:  Mol Ther       Date:  2011-12-20       Impact factor: 11.454

6.  Efficient in vitro siRNA delivery and intramuscular gene silencing using PEG-modified PAMAM dendrimers.

Authors:  Yin Tang; Yang-Bing Li; Bo Wang; Ri-Yuan Lin; Mallory van Dongen; Danielle M Zurcher; Xiao-Yan Gu; Mark M Banaszak Holl; George Liu; Rong Qi
Journal:  Mol Pharm       Date:  2012-05-14       Impact factor: 4.939

7.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs.

Authors:  Jürgen Soutschek; Akin Akinc; Birgit Bramlage; Klaus Charisse; Rainer Constien; Mary Donoghue; Sayda Elbashir; Anke Geick; Philipp Hadwiger; Jens Harborth; Matthias John; Venkitasamy Kesavan; Gary Lavine; Rajendra K Pandey; Timothy Racie; Kallanthottathil G Rajeev; Ingo Röhl; Ivanka Toudjarska; Gang Wang; Silvio Wuschko; David Bumcrot; Victor Koteliansky; Stefan Limmer; Muthiah Manoharan; Hans-Peter Vornlocher
Journal:  Nature       Date:  2004-11-11       Impact factor: 49.962

8.  Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles.

Authors:  David A Giljohann; Dwight S Seferos; Pinal C Patel; Jill E Millstone; Nathaniel L Rosi; Chad A Mirkin
Journal:  Nano Lett       Date:  2007-11-13       Impact factor: 11.189

9.  Immunological assay of pancreatic ribonuclease in serum as an indicator of pancreatic cancer.

Authors:  J L Weickmann; E M Olson; D G Glitz
Journal:  Cancer Res       Date:  1984-04       Impact factor: 12.701

10.  Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing.

Authors:  Jens Harborth; Sayda M Elbashir; Kim Vandenburgh; Heiko Manninga; Stephen A Scaringe; Klaus Weber; Thomas Tuschl
Journal:  Antisense Nucleic Acid Drug Dev       Date:  2003-04
View more
  27 in total

1.  Ribozyme-Spherical Nucleic Acids.

Authors:  Jessica L Rouge; Timothy L Sita; Liangliang Hao; Fotini M Kouri; William E Briley; Alexander H Stegh; Chad A Mirkin
Journal:  J Am Chem Soc       Date:  2015-08-14       Impact factor: 15.419

2.  Metallic Nanoparticles for Cancer Immunotherapy.

Authors:  Emily Reiser Evans; Pallavi Bugga; Vishwaratn Asthana; Rebekah Drezek
Journal:  Mater Today (Kidlington)       Date:  2017-12-14       Impact factor: 31.041

Review 3.  Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery.

Authors:  Byungji Kim; Ji-Ho Park; Michael J Sailor
Journal:  Adv Mater       Date:  2019-09-30       Impact factor: 30.849

4.  Controlling DNA-nanoparticle serum interactions.

Authors:  Kyryl Zagorovsky; Leo Y T Chou; Warren C W Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-16       Impact factor: 11.205

5.  Modular and Chemically Responsive Oligonucleotide "Bonds" in Nanoparticle Superlattices.

Authors:  Stacey N Barnaby; Ryan V Thaner; Michael B Ross; Keith A Brown; George C Schatz; Chad A Mirkin
Journal:  J Am Chem Soc       Date:  2015-10-14       Impact factor: 15.419

Review 6.  Composite nanoparticles for gene delivery.

Authors:  Yuhua Wang; Leaf Huang
Journal:  Adv Genet       Date:  2014       Impact factor: 1.944

7.  Self-Transfecting Micellar RNA: Modulating Nanoparticle Cell Interactions via High Density Display of Small Molecule Ligands on Micelle Coronas.

Authors:  Alexander Roloff; David A Nelles; Matthew P Thompson; Gene W Yeo; Nathan C Gianneschi
Journal:  Bioconjug Chem       Date:  2017-12-29       Impact factor: 4.774

8.  The effector mechanism of siRNA spherical nucleic acids.

Authors:  Gokay Yamankurt; Robert J Stawicki; Diana M Posadas; Joseph Q Nguyen; Richard W Carthew; Chad A Mirkin
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-03       Impact factor: 11.205

9.  Gold Nanoparticle Size and Shape Effects on Cellular Uptake and Intracellular Distribution of siRNA Nanoconstructs.

Authors:  Jun Yue; Timothy Joel Feliciano; Wenlong Li; Andrew Lee; Teri W Odom
Journal:  Bioconjug Chem       Date:  2017-06-12       Impact factor: 4.774

10.  SN-38 Conjugated Gold Nanoparticles Activated by Ewing Sarcoma Specific mRNAs Exhibit In Vitro and In Vivo Efficacy.

Authors:  Jordan A Naumann; John C Widen; Leslie A Jonart; Maryam Ebadi; Jian Tang; David J Gordon; Daniel A Harki; Peter M Gordon
Journal:  Bioconjug Chem       Date:  2018-02-19       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.